Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 23 Dec 2022  |  Global  |  Market Outlook

    Top 10 for 2023: Predictions for the Healthcare and Life Sciences Industry

    Predictions for the Healthcare and Life Sciences Industry

    The year 2023 will begin with three disruptive forces already playing out. The first is inflationary pressure on wages. The global labor market is expected to remain tight due to aging workforces and stringent immigration policies. The COVID-19 pandemic’s impact on labor force turnover rates will keep price inflation higher than pre-pandemic l...

    $2,450.00
  2. 07 Dec 2022  |  Global  |  Market Outlook

    Outlook 2023: Top 10 Growth Opportunities for Digital Health

    Predictions for the Digital Health Industry

    Healthcare during the COVID-19 pandemic has undeniably seen some of its most significant changes. The growth of digital health was a silver lining, and enterprise IT solution providers and telehealth vendors saw tremendous growth during this time. They will continue to see the same in the coming years. Digital health continued to have a winning str...

    $2,450.00
  3. 05 Dec 2022  |  Global  |  Market Outlook

    Outlook 2023: Top 10 Growth Opportunities for MedTech

    Growth Opportunities for the Medtech Industry

    Frost & Sullivan’s Medtech and Imaging programs explore, articulate, and address the medical industry’s most pressing questions related to growth. The programs focus on core segments such as care delivery, care management, imaging informatics, intelligent imaging, and business models. They independently review and identify companies that are pr...

    $2,450.00
  4. 15 Jul 2022  |  Global  |  Customer Research

    Frost & Sullivan Global Cloud User Survey, Q4 2021

    Transformational Growth in Hybrid Cloud and Multi-cloud Deployments Drive Digitalization in Healthcare

    This research service presents the findings of the global cloud user survey conducted by Frost & Sullivan between October 2021 and November 2021 to derive insights on cloud adoption, deployment, and usage. The primary goal of this research is to analyze the cloud computing technology adoption trends among healthcare organizations, including top bus...

    $4,950.00
  5. 01 Feb 2022  |  Global  |  Frost Radar

    Frost Radar™: Global Enterprise Health Cloud Infrastructure and Platform Services, 2021

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    The COVID-19 pandemic has revealed that many healthcare organizations have neither the agility and business continuity programs nor the technologies needed to support them during a crisis. Consequently, some have been forced to act on cloud and digital transformation strategies they had been delaying. The cloud has been critical in helping healthca...

    $4,950.00
  6. 22 Dec 2020  |  Global  |  Frost Radar

    Frost Radar™: Global Endoscopy Market, 2020

    A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

    Globally, the demand for minimally invasive surgeries is trending upward at a quick pace, so consequently the demand for innovative endoscopy devices used in these procedures is anticipated to surge in the mid-to-long term. Moreover, health systems will be forced to clear the backlogs of “elective surgeries” that were postponed due to the COVID...

    $4,950.00
  7. 15 Dec 2020  |  Global  |  Frost Radar

    Frost Radar™: Advanced Antibodies, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    With advances in antibody-based therapies, bispecific antibodies (bsAbs) have gained momentum in the last few years after the regulatory approvals of Amgens blinatumomab (Blincyto®) and Chugais Hemlibra for Hemophilia A. The key advantage of bsAbs lies in their ability to bind two different epitopes or antigens, thereby overcoming the limitations ...

    $4,950.00
  8. 09 Dec 2020  |  Global  |  Frost Radar

    Frost Radar™: Microbiome Therapeutics, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    Microbiome present in the human body has a major role to play in the overall functioning of the human body. Human microbiota consists of a diverse population of bacterial, viral and eukaryotic communities and is present on skin, nasopharynx, oral cavity, respiratory tract, gastrointestinal tract and female reproductive tract. The naturally occurri...

    $4,950.00
  9. 04 Dec 2020  |  Global  |  Frost Radar

    Frost Radar™: Digital Biomarkers Through Connected Devices, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditu...

    $4,950.00
  10. 29 Oct 2020  |  Global  |  Frost Radar

    Frost Radar™:Transformative Influenza Vaccines, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    Influenza causes respiratory diseases and often leads to large epidemics. Every year about 290,000 to 650,000 people die due to influenza worldwide. Anti-viral drugs available to treat influenza have many limitations making vaccination the most effective tool to prevent seasonal and pandemic influenza outbreaks. Influenza vaccination is highly reco...

    $4,950.00